Skip to main content
OpenTrials
Completed

NCT Number: NCT02643173

Hepatocellular Carcinoma Recurrence and Anesthesia

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing surgery due to the HCC.

Exclusion criteria

  • Patients undergoing re-operation due to the HCC.
  • Patients presenting distant metastasis.
  • Patients undergoing liver transplantation surgery.

Treatment and study plan

Volatile anesthetics

Other

Intravenous anesthetics

Other

Primary outcomes

  1. Recurrence of HCC

    Time frame: Postoperative 2 year

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Dec 31, 2015
Registry last updated
Nov 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.